胃祺饮加减治疗慢性萎缩性胃炎临床疗效评价
|
摘要
目的:对胃祺饮加减药物治疗慢性萎缩性胃炎进行临床疗效评价。方法:通过对治疗前后患者症状及胃镜病理变化的综合分析,评价胃祺饮加减方的临床疗效。结果:胃祺饮加减方对萎缩性胃炎患者症状改善的总有效率为87.67%,对胃黏膜病理有逆转作用。结论:胃祺饮加减方作为治疗慢性萎缩性胃炎的协定方药,疗效确切,值得推广使用。
Objective:To evaluate the clinical efficacy of Modified Weiqi Decoction in patients with chronic atrophic gastritis.Methods:Through comprehensive analysis of the symptoms of patients before and after treatment and the pathological changes of gastroscopy,we evaluated the clinical effect of Modified Weiqi Decoction.Results:Modified Weiqi Decoction is effective in improving symptoms of CAG with total effective rate being 87.67%.It has a reversal effect on gastric mucosal pathology.Conclusion:Modified Weiqi Decoction is effective in treating CAG and it deserves further promotion.
Objective:To evaluate the clinical efficacy of Modified Weiqi Decoction in patients with chronic atrophic gastritis.Methods:Through comprehensive analysis of the symptoms of patients before and after treatment and the pathological changes of gastroscopy,we evaluated the clinical effect of Modified Weiqi Decoction.Results:Modified Weiqi Decoction is effective in improving symptoms of CAG with total effective rate being 87.67%.It has a reversal effect on gastric mucosal pathology.Conclusion:Modified Weiqi Decoction is effective in treating CAG and it deserves further promotion.
引文
[1] 孟静岩.慢性萎缩性胃炎[M].北京:中医药科技出版社,2003:1-41
[2] 中华中医药学会脾胃病分会.慢性萎缩性胃炎中医诊疗共识意见.中医杂志,2010,51(8):749-753
[3] 房静远,刘文忠,李兆申,等.中国慢性胃炎共识意见[J].胃肠病学,2013,33(1):24-36.
[4] Correa P.A human model of gastric carcinogenesis[J].Cancer Res,1988,48(13):3554-3560.
[5] 姜宁,黄宣,范一宏,等.中西医结合治疗胃癌前病变疗效的系统评价[J].中华中医药学刊,2015,24(1):149-154.
[6] 胡鸿毅,郑红斌,陆雄,等.胃祺饮阻断胃癌前病变组织增殖作用的实验研究[J].中国中西医结合消化杂志,2001(1):32-34.
[7] 胡鸿毅,郑红斌,陆雄,等.胃祺饮阻断慢性萎缩性胃炎的机制[J].中国中西医结合消化杂志,2001,9(2):94-96.
[8] 戴彦成,尤毅梅,唐志鹏,等.胃祺饮治疗慢性萎缩性胃炎的临床和实验研究述评[J].中华中医药学刊,2013,31(10):2240-2241.
[9] 谢建群,马贵同,程焕章,等.胃祺饮防治慢性萎缩性胃炎的临床及实验研究[J].上海中医药杂志,1993(10):12-16.
[10] 李益农,陆星华.消化内镜学[M].北京:科学出版社,2006.
[11] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:125-126.
[12]洪原淑.马贵同辨治慢性萎缩性胃炎经验[J].上海中医药杂志,2007,41(8):11-13.
[13]潘相学,袁建业.谢建群治疗胃黏膜癌前病变经验[J].江西中医药,2004,35(5):8-9.
[14]薛筠,谢建群.谢建群辨治慢性胃炎临证经验[J].上海中医药杂志,2005,39(5):12-13
[15]朱凌宇,顾贤.马贵同治疗慢性萎缩性胃炎经验[J].浙江中医杂志,2007,42(5):290-291
[16]卢璐.谢建群辨治慢性萎缩性胃炎经验拾零[J].上海中医药杂志,2009,43(12):10-11.
[2] 中华中医药学会脾胃病分会.慢性萎缩性胃炎中医诊疗共识意见.中医杂志,2010,51(8):749-753
[3] 房静远,刘文忠,李兆申,等.中国慢性胃炎共识意见[J].胃肠病学,2013,33(1):24-36.
[4] Correa P.A human model of gastric carcinogenesis[J].Cancer Res,1988,48(13):3554-3560.
[5] 姜宁,黄宣,范一宏,等.中西医结合治疗胃癌前病变疗效的系统评价[J].中华中医药学刊,2015,24(1):149-154.
[6] 胡鸿毅,郑红斌,陆雄,等.胃祺饮阻断胃癌前病变组织增殖作用的实验研究[J].中国中西医结合消化杂志,2001(1):32-34.
[7] 胡鸿毅,郑红斌,陆雄,等.胃祺饮阻断慢性萎缩性胃炎的机制[J].中国中西医结合消化杂志,2001,9(2):94-96.
[8] 戴彦成,尤毅梅,唐志鹏,等.胃祺饮治疗慢性萎缩性胃炎的临床和实验研究述评[J].中华中医药学刊,2013,31(10):2240-2241.
[9] 谢建群,马贵同,程焕章,等.胃祺饮防治慢性萎缩性胃炎的临床及实验研究[J].上海中医药杂志,1993(10):12-16.
[10] 李益农,陆星华.消化内镜学[M].北京:科学出版社,2006.
[11] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:125-126.
[12]洪原淑.马贵同辨治慢性萎缩性胃炎经验[J].上海中医药杂志,2007,41(8):11-13.
[13]潘相学,袁建业.谢建群治疗胃黏膜癌前病变经验[J].江西中医药,2004,35(5):8-9.
[14]薛筠,谢建群.谢建群辨治慢性胃炎临证经验[J].上海中医药杂志,2005,39(5):12-13
[15]朱凌宇,顾贤.马贵同治疗慢性萎缩性胃炎经验[J].浙江中医杂志,2007,42(5):290-291
[16]卢璐.谢建群辨治慢性萎缩性胃炎经验拾零[J].上海中医药杂志,2009,43(12):10-11.